Results 261 to 270 of about 1,148,410 (327)
Some of the next articles are maybe not open access.

Patents, Pharmaceutical Industry and Healthcare

Pharmaceutical Patent Analyst, 2023
[Abstract Not Available]
Ruqaiyyah Siddiqui, Naveed A Khan
openaire   +3 more sources

Patenting Pharmaceuticals in China

Pharmaceutical Patent Analyst, 2016
The pharmaceutical industry is developing fast in China and the market is getting more mature in recent years, which draws the attention of multinational producers and investors. Patent protection is important for the commercialization of pharmaceuticals in China.
Weiwei, Han, Juhua, Luo
openaire   +2 more sources

Law on Pharmaceutical Patents

SSRN Electronic Journal, 2012
India is known as the global pharmaceutical capital because of the ever growing generic drug manufacturing industry. With the growth of such an industry the issue of protection to pharmaceutical patents is also gaining importance. Pharmaceutical patent protection is of prime importance to pharma companies because of the huge amount of money invested in
M. Chatterjee
semanticscholar   +2 more sources

Problem pharmaceutical patents

World Patent Information, 1996
Abstract These days, the number of pharmaceutical patent applications which do not specify the principal active ingredient in the form of a chemical name or structure is increasing. These patents are difficult to retrieve in retrospective on-line searches using chemical structures or keywords.
Masaharu Kubo, Yukinori Itoh
openaire   +1 more source

Gene Patents—A Pharmaceutical Perspective

Cambridge Quarterly of Healthcare Ethics, 1998
The decade-long debate over ownership of living human materials has recently intensified with the ability of biomedical research to isolate, purify, and use human genes and gene products as therapeutics, factories for the production of therapeutics, and targets for the identification of therapeutic pharmaceuticals.
openaire   +2 more sources

Patent citation analysis of Allergan pharmaceutical patents

Expert Opinion on Therapeutic Patents, 1998
This is the second in a series of articles that apply patent citation analysis techniques to pharmaceutical patents. Co-citation clustering was used to identify the core pharmaceutical technological competencies of Allergan, Inc. and the technology fronts that this company is advancing.
Mary Ellen Mogee, Richard G Kolar
openaire   +1 more source

Pharmaceutical patents and price controls

Clinical Therapeutics, 2002
Since 1995, every member-country of the World Trade Organization (WTO) has agreed to honor a 20-year patent-life, from the date of a pharmaceutical company's application for the patent, in the country of application. Patent protection retards competitive imitation of an invented product.
openaire   +2 more sources

Pharmaceutical Patents: Incentives for R&D or Marketing?

Social Science Research Network, 2008
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry ...
Kurt R. Brekke   +3 more
semanticscholar   +1 more source

Pharmaceutical Patents and Healthcare

Socio-Legal Review, 2006
An essay on how the post-T.R.I.P.S.
openaire   +1 more source

Drafting Pharmaceutical Patents

2011
Abstract This chapter surveys the drafting of pharmaceutical patents across Australia, Canada, China, India, Japan, the United States, and Europe, explaining jurisdiction-specific practices and legal frameworks. It defines patentable subject matter, outlines permissible claim types, and prescribes requirements for pharmaceutical ...
openaire   +1 more source

Home - About - Disclaimer - Privacy